Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $13 | $21 | $80 |
| - Cash | $0 | $15 | $51 | $91 |
| + Debt | $3 | $0 | $0 | $0 |
| Enterprise Value | $5 | -$2 | -$30 | -$11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15 | -$49 | -$45 | -$33 |
| % Margin | – | – | – | – |
| Net Income | -$13 | -$49 | -$42 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -107.348 | -616.072 | -594.75 | -465.52 |
| % Growth | 82.6% | -3.6% | -27.8% | – |
| Operating Cash Flow | -$18 | -$41 | -$35 | -$31 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$41 | -$35 | -$31 |